DKC1 and dyskeratosis congenita: Evidence from another mouse model shows that cells with a Dkc1 mutation observed in human cases of DC suffer a growth disadvantage that may be due to activation of a DNA damage response that, while acting via telomerase, is independent of telomere length [63].